原发性肝细胞癌中[68Ga]Ga-FAPI-04的放射性分布模式
结果显示FAPI-04在肿瘤边缘的摄取显著高于中心(SUVmax P<0.001;SUVmean P<0.01),随SUVmax阈值升高,FAPI感兴趣体积集中于边缘、中心 sharply 减少。结论认为[68Ga]Ga-FAPI-04 PET/CT显示HCC边缘高摄取和明显的中心异质性(低SUV中心)。
要点
- HCC中[68Ga]Ga-FAPI-04边缘摄取显著高于中心。
- 随SUVmax阈值升高,FAPI摄取集中于边缘、中心减少。
- 边缘高摄取支持FAP靶向荧光引导手术及边缘残留/复发治疗。
核心结论
- [68Ga]Ga-FAPI-04 PET/CT在HCC中表现为边缘高摄取和明显的中心异质性(低SUV中心)。
- 边缘强摄取支持FAP靶向荧光引导手术和针对边缘残留/复发疾病的靶向治疗。
- 中心低摄取可能限制FAP靶向治疗。
研究设计与样本
- 患者在一周内同时接受[18F]FDG和[68Ga]Ga-FAPI-04 PET/CT检查。
- 比较肿瘤边缘与中心的摄取。
主要发现
- FAPI-04在肿瘤边缘的摄取显著高于中心(SUVmax,P<0.001;SUVmean,P<0.01)。
- 随着SUVmax阈值升高,FAPI感兴趣体积集中于边缘,中心 sharply 减少。
临床怎么用
- 可利用[68Ga]Ga-FAPI-04 PET/CT边缘高摄取特征支持FAP靶向荧光引导手术。
- 边缘强摄取支持针对边缘残留/复发疾病的靶向治疗。
- 中心低摄取可能限制FAP靶向治疗的应用。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To evaluate the radioactive distribution patterns of [ 68 Ga]Ga-FAPI-04 in primary hepatocellular carcinoma (HCC). METHODS: Twenty-three primary HCC patients (26 lesions) from a prospective trial (ChiCTR2000039099) underwent both [ 18 F]FDG and [ 68 Ga]Ga-FAPI-04 PET/CT within 1 week. Uptake at tumor margins versus centers was compared. RESULTS: FAPI-04 uptake was significantly higher at tumor margins than centers (SUVmax, P <0.001; SUVmean, P <0.01). As SUVmax thresholds increased, FAPI volume of interest concentrated at the margins and decreased sharply in the centers. CONCLUSIONS: [ 68 Ga]Ga-FAPI-04 PET/CT demonstrated higher marginal uptake and pronounced central heterogeneity (low-SUV centers) in HCC. Strong peripheral uptake supports the use of FAP-targeted fluorescence-guided surgery and targeted treatment of marginal residual/recurrent disease, while low central uptake may limit FAP-targeted therapy.
引用
- Zhu D, Zhu Y, Zou S, et al. Radioactive Distribution Patterns of [ 68 Ga]Ga-FAPI-04 in Primary Hepatocellular Carcinoma. Clin Nucl Med. 2026. PMID: 41649855. doi:10.1097/RLU.0000000000006345
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。